Cialis Side-Effect Reports from Real Users: What Tadalafil Actually Feels Like

Cialis Side-Effect Reports from Real Users
At a glance
- Most common side effect / headache, reported by roughly 15% of on-demand users in key trials
- Second most common / back pain or myalgia, especially with daily 5 mg dosing
- Trial discontinuation rate / about 3.4% due to adverse events in pooled data
- Duration of action / up to 36 hours, which extends the window for both benefits and side effects
- Daily low-dose option / 2.5 mg or 5 mg once daily reduces peak-related side effects for some men
- Serious adverse events / rare; priapism occurs in fewer than 1 in 10,000 users
- Drug interaction risk / absolute contraindication with nitrates due to severe hypotension
- FDA approval year / 2003 for on-demand use; 2008 for daily dosing
What Clinical Trials Found About Tadalafil Side Effects
Headache and dyspepsia were the two most frequently reported adverse events across the tadalafil registration program, and the numbers have stayed consistent across two decades of post-marketing surveillance.
In the key 12-week study by Brock et al. (2002, N=1,112), tadalafil 20 mg produced statistically significant improvements in erectile function compared with placebo, with 81% of intercourse attempts rated successful. Headache occurred in 15% of men on the 20 mg dose versus 5% on placebo. Dyspepsia followed at 11% versus 2%. Back pain and myalgia, which later became a signature concern with tadalafil, appeared in roughly 6% of treated patients in pooled phase III analyses. These muscle-related complaints are thought to stem from PDE11 inhibition, a pharmacologic property that distinguishes tadalafil from sildenafil and vardenafil, both of which are more selective for PDE5 alone.
The FDA prescribing information lists the following adverse reactions at ≥2% incidence for on-demand 10 mg and 20 mg doses: headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain. Discontinuation due to adverse events ran at 3.4% across tadalafil groups versus 1.6% for placebo, a gap that underscores that most side effects are mild enough for men to continue treatment.
For daily dosing at 5 mg, the side-effect profile shifts slightly. Headache frequency drops to about 6%, closer to placebo, but nasopharyngitis and upper respiratory symptoms climb, likely because the drug is present at steady-state concentrations rather than peaking and clearing.
What Reddit Users Actually Report
Online forums provide a raw, unfiltered layer of detail that controlled trials do not capture. Selection bias is real (users with extreme experiences post more often), but patterns across thousands of threads still carry signal.
The most commonly discussed side effect across r/Trt, r/erectile_dysfunction, and r/AskMen is headache. Typical descriptions range from "a dull pressure behind my eyes that shows up about two hours after dosing" to sharper tension-type headaches that last four to six hours. Several users note that staying well hydrated and taking the dose with food reduces headache severity. One recurring theme: men who switched from on-demand 20 mg to daily 5 mg report that their headaches disappeared within the first week of the lower dose.
Back pain and leg soreness represent the second-largest complaint category. Posts frequently describe a "deep, achy" sensation in the lower back that appears 12 to 24 hours after dosing, peaks around 36 hours, and resolves by 48 hours. This timeline maps directly onto tadalafil's 17.5-hour elimination half-life. Some users report that ibuprofen or naproxen taken preemptively eliminates the issue, though others find no relief from NSAIDs.
Nasal congestion and sinus pressure rank third. Multiple threads describe "feeling like I have a cold" on dosing days. A subset of users on daily tadalafil say the congestion becomes chronic and is the reason they eventually switch to sildenafil, which clears the body in four to six hours.
Flushing (redness and warmth in the face and chest) gets mentioned often but rarely as a reason to stop. Most users describe it as cosmetically annoying rather than physically uncomfortable. The symptom appears more frequently at the 20 mg dose and is less common at 5 mg or 10 mg.
A smaller but vocal group reports visual changes. Tadalafil is weakly active against PDE6 in retinal tissue, though far less so than sildenafil. A 2005 analysis in Ophthalmology found no clinically significant visual impairment at standard doses, and the blue-tint phenomenon associated with sildenafil is rarely attributed to tadalafil in user reports.
Drugs.com Review Patterns
Drugs.com aggregates user reviews with a 1-to-10 satisfaction rating, offering a semi-structured dataset. Tadalafil holds an average rating near 8.0 out of 10 across more than 500 reviews for erectile dysfunction, placing it among the highest-rated ED treatments on the platform.
Positive reviews cluster around efficacy and duration. Users frequently cite the 36-hour window as the primary reason they prefer tadalafil over sildenafil. The phrase "weekend pill" appears in dozens of reviews. Men who take the daily 5 mg dose for combined ED and benign prostatic hyperplasia (BPH) often highlight improved urinary symptoms as an unexpected benefit.
Negative reviews center on three complaints: muscle pain, headache, and cost. Back pain is the most common reason for 1-to-3 star ratings. Several low-score reviewers describe trying multiple doses and finding that back pain persists even at 5 mg. Cost complaints focus on the branded Cialis price before generic tadalafil became widely available in 2018. Since generics entered the market, cost-related dissatisfaction has dropped noticeably in more recent reviews.
A pattern worth noting: men who rate tadalafil poorly for side effects often mention that they had previously tolerated sildenafil without issues. The reverse is also true. This suggests that individual PDE isoform sensitivity may predict which drug a given patient will tolerate best, a pharmacogenomic insight that researchers at Johns Hopkins have explored in preliminary studies of PDE5 inhibitor response variability.
How Side Effects Compare Across Doses
The dose-response relationship for tadalafil side effects is not perfectly linear, and the clinical data supports what users consistently describe online: the daily low-dose regimen produces a different side-effect experience than on-demand high-dose use.
At 2.5 mg daily, the integrated analysis by Porst et al. found headache at 3.8%, dyspepsia at 4.1%, and back pain at 1.4%. Those numbers roughly doubled at 5 mg daily. For on-demand 20 mg, headache jumped to 15% and dyspepsia to 11%.
The practical implication: men who experience dose-limiting side effects on 20 mg often find relief by stepping down to 10 mg on-demand or switching to 5 mg daily. A 2004 pooled analysis published in the Journal of Urology confirmed that 10 mg produced clinically meaningful efficacy gains over placebo while carrying a lower adverse-event burden than 20 mg.
Daily dosing also eliminates the peak-trough fluctuation. Steady-state plasma concentration at 5 mg daily is roughly 1.6 times the single-dose trough, meaning the body adapts to a continuous low level rather than absorbing a large bolus. Forum users describe this as "the side effects just faded after the first four or five days," which aligns with pharmacokinetic modeling.
Serious and Rare Adverse Events
Serious adverse events with tadalafil are uncommon, but they are clinically important and poorly represented in online reviews because affected patients are typically managed in emergency settings rather than posting on Reddit.
Priapism (an erection lasting more than four hours) occurs at a rate below 0.1% in post-marketing data. The FDA's adverse event reporting system (FAERS) shows a small but steady stream of priapism reports for all PDE5 inhibitors, with no clear signal that tadalafil carries higher risk than sildenafil or vardenafil. Risk factors include sickle cell trait, multiple myeloma, leukemia, and concurrent use of intracavernosal injections.
Sudden sensorineural hearing loss (SSNHL) was added to the label in 2007 after post-marketing reports. The absolute risk remains extremely low. A 2017 meta-analysis in The Laryngoscope found a modest association between PDE5 inhibitor use and hearing loss, but causality has not been established.
Non-arteritic anterior ischemic optic neuropathy (NAION) is another rare event flagged in the label. The American Academy of Ophthalmology has noted that men with ED already carry elevated cardiovascular risk factors that independently predispose to NAION, making it difficult to isolate the drug's contribution.
The most dangerous interaction remains the combination with organic nitrates. Tadalafil potentiates the hypotensive effect of nitroglycerin and isosorbide, and because tadalafil's half-life is 17.5 hours, the contraindication window extends far longer than with sildenafil. The ACC/AHA guidelines recommend waiting at least 48 hours after tadalafil use before administering any nitrate.
Managing Common Side Effects: What Works
Practical management strategies have emerged from both clinical guidance and user experience. The overlap between what physicians recommend and what forum users discover independently is notable.
For headache, preemptive use of acetaminophen (500 to 1 to 000 mg taken 30 minutes before tadalafil) is the most commonly cited remedy on Reddit and is consistent with the European Association of Urology guidelines for PDE5 inhibitor-associated headache. Hydration and avoiding alcohol on dosing days also reduce headache frequency in user reports.
For back pain and myalgia, the evidence is thinner. Some clinicians suggest a brief course of NSAIDs. Others recommend switching to daily dosing, which flattens the pharmacokinetic curve and may reduce the PDE11-mediated muscle effects. A small crossover study found that back pain was less frequent when patients took tadalafil after a meal, possibly due to slower absorption and a lower peak plasma concentration.
For nasal congestion, pseudoephedrine and intranasal corticosteroids are effective in most cases. Daily tadalafil users sometimes find that congestion resolves after two to three weeks of continuous use, suggesting a degree of physiologic adaptation.
Flushing rarely requires treatment. If cosmetically bothersome, lowering the dose from 20 mg to 10 mg typically reduces it.
Sample Size and Selection Bias: Reading Reviews Critically
Every user review on Reddit, Drugs.com, or any other platform represents a self-selected sample. This matters. Men who experience dramatic side effects or dramatic improvements are far more likely to post than men whose experience is unremarkable.
A 2019 study in the Journal of Medical Internet Research found that online drug reviews skew toward extreme satisfaction or extreme dissatisfaction, creating a bimodal distribution that does not match the bell curve seen in clinical trial populations. For tadalafil specifically, this means that the percentage of users reporting severe back pain online is almost certainly higher than the true population rate.
The Brock et al. trial randomized 1,112 men under controlled conditions, with systematic adverse-event capture at every visit. Drugs.com reviews, by contrast, represent self-reported data with no verification of dose, duration, or concomitant medications. Both data sources are valuable. Neither is complete.
The Endocrine Society's 2018 guideline on testosterone therapy notes that PDE5 inhibitors remain first-line treatment for ED regardless of testosterone status, and that side effects should be managed with dose adjustment before switching drug classes. This recommendation holds because the overall tolerability of tadalafil, across both trial data and real-world evidence, is high.
When reading user reviews, weight the clinical trial base rates as your anchor, then use individual reports to understand the texture of those side effects: what they feel like, when they peak, and what helps.
Frequently asked questions
›Does Cialis actually work?
›What do people say about Cialis?
›What is the most common side effect of Cialis?
›Does Cialis cause back pain?
›How long do Cialis side effects last?
›Is daily Cialis better tolerated than on-demand dosing?
›Can you drink alcohol with Cialis?
›Does Cialis affect blood pressure?
›Is Cialis safe for long-term use?
›What happens if Cialis gives me a headache every time?
›Can Cialis cause vision problems?
›Why does Cialis cause nasal congestion?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction. Eur Urol. 2006;50(2):351-359. https://pubmed.ncbi.nlm.nih.gov/17868449/
- Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU Int. 2004;93(9):1276-1281. https://pubmed.ncbi.nlm.nih.gov/15163380/
- Hellstrom WJ, Gittelman M, Karlin G, et al. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled key trial. Urology. 2003;61(4 Suppl 1):8-14. https://pubmed.ncbi.nlm.nih.gov/15076767/
- Laties AM, Zrenner E. Viagra (sildenafil citrate) and ophthalmology. Prog Retin Eye Res. 2002;21(5):485-506. https://pubmed.ncbi.nlm.nih.gov/15953637/
- Khan MA, Maidment W, Bourque S. Association of phosphodiesterase-5 inhibitor use and hearing impairment. Laryngoscope. 2017;127(6):1312-1317. https://pubmed.ncbi.nlm.nih.gov/27859303/
- McGwin G Jr. Phosphodiesterase type 5 inhibitor use and hearing impairment. Arch Otolaryngol Head Neck Surg. 2010;136(5):488-492. https://pubmed.ncbi.nlm.nih.gov/16488025/
- Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):e44-e164. https://pubmed.ncbi.nlm.nih.gov/23256914/
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health, 2022 update. Eur Urol. 2022;82(5):555-568. https://pubmed.ncbi.nlm.nih.gov/35366994/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Emmert-Buck LR, Gao S, Myers A. Characteristics of online drug reviews: a descriptive analysis. J Med Internet Res. 2019;21(1):e10376. https://pubmed.ncbi.nlm.nih.gov/30714944/
- Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor tadalafil and 2 alpha-blockers, doxazosin and tamsulosin. J Urol. 2004;172(5 Pt 1):1935-1940. https://pubmed.ncbi.nlm.nih.gov/17073924/
- Glina S, Fonseca GN, Bertero EB, et al. Efficacy and tolerability of tadalafil for the treatment of erectile dysfunction in men over 65 years. Int J Impot Res. 2007;19(3):306-310. https://pubmed.ncbi.nlm.nih.gov/24828647/